GeneMetrics Enables 72 Hour Launch For Fully Branded Genetic Testing

GeneMetrics Eliminates The Lab With 72 Hour Launch For Fully Branded Genetic Testing

Austin, United States – June 7, 2026 / GeneMetrics /

FOR IMMEDIATE RELEASE

Austin, TX — June 5th, 2026

GeneMetrics, a white-label genetic testing platform built for healthcare practitioners and wellness brands, today announced the expanded availability of its Beyond-White-Label™ model, enabling licensed clinics, medical spas, supplement companies, and health technology builders to deploy fully branded DNA testing services in as little as 72 hours. The offering covers end-to-end fulfillment, from kit logistics and laboratory processing to bioinformatics pipelines and patient-facing report generation, under the client’s own brand name. Clients retain full ownership of their data throughout the process.

KEY FACTS

72-hour launch window for new branded genetic testing platforms using GeneMetrics’ end-to-end fulfillment model

HIPAA and GDPR compliant infrastructure with multi-level encryption across all data handling and storage layers

Customizable sequencing depth ranging from targeted panel diagnostics to whole genome sequencing, configurable per client use case

Clients own their data: GeneMetrics does not retain, resell, or license patient genomic data to third parties

Pharmacogenomics testing included as a configurable module, enabling medication response insights for clinical practitioners

Zero lab infrastructure required: bioinformatics, report generation, and logistics are fully managed by GeneMetrics

The Infrastructure Problem Practitioners Actually Face

For most licensed practitioners considering genetic testing, the barrier has never been patient demand. It has been operational complexity. Building a compliant genomics program from scratch requires CLIA-certified laboratory partnerships, bioinformatics staff, regulatory alignment under HIPAA’s genomic data guidance, and patient-facing reporting design that meets clinical communication standards. According to a 2024 report by KLAS Research on specialty diagnostic adoption, operational complexity and upfront infrastructure cost are cited as the top two reasons ambulatory clinics delay or abandon specialty testing programs entirely.

GeneMetrics addresses this directly through its Beyond-White-Label™ model, which is not simply co-branded kit fulfillment. Clients configure their sequencing scope, from pharmacogenomics panels relevant to prescribing practitioners, to multi-marker wellness panels suited for med spas, to broader whole-genome options for health technology integrations, and receive a fully managed back end with no laboratory buildout required. The result is a branded genetic testing product that a clinic or wellness brand can present to patients as entirely their own, backed by GeneMetrics’ clinical and bioinformatics infrastructure. Practitioners evaluating whether this approach fits their practice can find an honest tradeoff analysis for health professionals comparing white-label DNA testing against the available alternatives.

Where Practitioners Report the Clearest Value

Consider a scenario familiar to many integrative medicine clinic owners: a practitioner adds a nutrigenomics panel to her existing supplement protocol consultations. Previously, she referred patients to direct-to-consumer services like 23andMe, losing both the revenue opportunity and control over how results were communicated. Using GeneMetrics’ platform, she launched a fully branded “Precision Wellness” test under her clinic name within three days of onboarding, with actionable reports formatted for patient comprehension and clinical follow-up rather than the consumer-facing ancestry framing that DTC services prioritize. Practitioners using this approach report an average of two to three additional consultation touchpoints per patient per year, driven by report-guided follow-up care.

It is worth noting a genuine tradeoff: the 72-hour launch timeline applies to practitioners adopting a standard configuration. Clients requiring deep custom bioinformatics pipelines, novel biomarker panels, or health app API integrations should expect a longer scoping and implementation phase. GeneMetrics positions its platform as the right fit for practitioners ready to deploy proven genetic insight frameworks, not as a bespoke research and development partner for novel diagnostic development. Teams moving too quickly without proper planning risk making the white-label DNA testing mistakes that kill promising programs before they launch.

Data Ownership as a Clinical and Competitive Differentiator

At a time when genomic data privacy is under increased regulatory scrutiny, including proposed amendments to HIPAA’s definition of protected health information to explicitly cover genomic identifiers that are currently under HHS review, the question of who owns patient data is no longer a fine-print concern. GeneMetrics structures all client agreements around a clear principle: client organizations retain full ownership of the genomic data generated through their branded platform. GeneMetrics does not use that data for secondary research, third-party licensing, or model training. The technical architecture behind this commitment is detailed in GeneMetrics’ documentation on multi-tenant isolation, bioinformatics throughput, and HIPAA-compliant delivery at scale.

“Most practitioners don’t realize that when they refer patients to a direct-to-consumer platform, they’ve ceded both the revenue and the data relationship,” said a GeneMetrics platform lead. “Our model inverts that. The practitioner’s brand is on the report, the data lives in their account, and the patient relationship stays exactly where it belongs: with the provider.”

“The 72-hour benchmark is real, but what matters more is what happens after launch,” added a member of GeneMetrics’ client implementation team. “We built the fulfillment layer so practitioners can focus on interpreting insights and building patient relationships, not on managing kit inventory or chasing lab turnaround times.”

About GeneMetrics

GeneMetrics is a white-label genetic testing platform that enables licensed healthcare practitioners, clinics, wellness brands, and health technology companies to offer fully branded DNA testing services without building laboratory infrastructure. The company’s Beyond-White-Label™ model covers end-to-end fulfillment, including laboratory processing, bioinformatics analysis, and clinically backed report generation, under each client’s own brand. GeneMetrics operates under HIPAA and GDPR compliance frameworks with multi-level data encryption, and clients retain full ownership of all genomic data generated through their platforms. Learn more at genemetrics.com.

Media Contact

GeneMetrics

6507 Jester Blvd

Austin, Texas 78750

United States

Chris Haas

+1 898202601

https://genemetrics.com